Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)

CUSIP: 04746L104

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, $0.0001 Par Value
Shares outstanding
9,614,000
Total 13F shares
26,188,389
Share change
+1,248,046
Total reported value
$341,210,519
Put/Call ratio
56%
Price per share
$13.03
Number of holders
97
Value change
+$17,550,511
Number of buys
44
Number of sells
41

Quarterly Holders Quick Answers

What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PERCEPTIVE ADVISORS LLC
13F
Company
36%
3,425,916
$32,135,000 30 Sep 2021
13F
FRANKLIN RESOURCES INC
13F
Company
22%
2,082,920
$19,538,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
21%
2,008,903
$18,845,000 30 Sep 2021
13F
RTW INVESTMENTS, LP
13F
Company
20%
1,906,557
$17,884,000 30 Sep 2021
13F
Logos Global Management LP
13F
Company
19%
1,855,812
$17,408,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
17%
1,641,483
$15,397,000 30 Sep 2021
13F
VR Adviser, LLC
13F
Company
12%
1,196,196
$11,220,000 30 Sep 2021
13F
PATHSTONE FAMILY OFFICE, LLC
13F
Company
12%
1,146,447
$10,754,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
12%
1,135,549
$10,652,000 30 Sep 2021
13F
WASATCH ADVISORS LP
13F
Company
9.3%
896,283
$8,407,000 30 Sep 2021
13F
BAKER BROS. ADVISORS LP
13F
Company
8.4%
806,367
$7,564,000 30 Sep 2021
13F
Bristlecone Advisors, LLC
13F
Company
7.9%
761,563
$7,143,000 30 Sep 2021
13F
Rock Springs Capital Management LP
13F
Company
5.7%
552,252
$5,180,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
5%
485,253
$4,552,000 30 Sep 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
4.6%
442,120
$4,147,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
4%
385,748
$3,618,000 30 Sep 2021
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
3.1%
297,362
$2,789,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
3%
289,072
$2,711,000 30 Sep 2021
13F
CITIGROUP INC
13F
Company
2.5%
242,064
$2,271,000 30 Sep 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
2.4%
232,209
$2,178,000 30 Sep 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
2.3%
223,201
$2,094,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
2.2%
213,231
$2,001,000 30 Sep 2021
13F
Hudson Bay Capital Management LP
13F
Company
2.1%
200,000
$1,876,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
1.9%
178,742
$1,677,000 30 Sep 2021
13F
DAFNA Capital Management LLC
13F
Company
1.7%
160,983
$1,510,000 30 Sep 2021
13F
Nuveen Asset Management, LLC
13F
Company
1.3%
125,083
$1,267,000 30 Sep 2021
13F
Russell Investments Group, Ltd.
13F
Company
1.4%
135,057
$1,265,000 30 Sep 2021
13F
OSAIC HOLDINGS, INC.
13F
Company
1.4%
130,894
$1,227,000 30 Sep 2021
13F
Pentwater Capital Management LP
13F
Company
1.2%
120,000
$1,126,000 30 Sep 2021
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
1.2%
114,167
$1,071,000 30 Sep 2021
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
1.1%
106,388
$998,000 30 Sep 2021
13F
ROYAL BANK OF CANADA
13F
Company
1.1%
101,513
$952,000 30 Sep 2021
13F
Bank of New York Mellon Corp
13F
Company
1%
97,401
$914,000 30 Sep 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.97%
93,495
$877,000 30 Sep 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.89%
86,033
$807,000 30 Sep 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.85%
81,765
$767,000 30 Sep 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.78%
74,900
$703,000 30 Sep 2021
13F
UBS Group AG
13F
Company
0.71%
68,694
$644,000 30 Sep 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.57%
54,800
$514,000 30 Sep 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.55%
52,733
$495,000 30 Sep 2021
13F
IEQ CAPITAL, LLC
13F
Company
0.52%
49,922
$468,000 30 Sep 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.43%
41,760
$392,000 30 Sep 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.4%
38,480
$361,000 30 Sep 2021
13F
EMC Capital Management
13F
Company
0.28%
26,487
$346,000 30 Sep 2021
13F
Cubist Systematic Strategies, LLC
13F
Company
0.38%
36,567
$343,000 30 Sep 2021
13F
Jump Financial, LLC
13F
Company
0.38%
36,307
$341,000 30 Sep 2021
13F
SIMPLEX TRADING, LLC
13F
Company
0.31%
29,474
$312,000 30 Sep 2021
13F
Clarius Group, LLC
13F
Company
0.34%
33,066
$310,000 30 Sep 2021
13F
HAP Trading, LLC
13F
Company
0.29%
27,881
$262,000 30 Sep 2021
13F
ROTHSCHILD INVESTMENT LLC /IL
13F
Company
0.23%
21,850
$205,000 30 Sep 2021
13F

Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q4 2021

As of 31 Dec 2021, Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by 97 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,188,389 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, BlackRock Inc., FRANKLIN RESOURCES INC, RTW INVESTMENTS, LP, Logos Global Management LP, VANGUARD GROUP INC, PATHSTONE FAMILY OFFICE, LLC, WASATCH ADVISORS INC, VR Adviser, LLC, and BAKER BROS. ADVISORS LP. This page lists 97 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
91
Q4 2021 holders
97
Holder diff
6
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.